Community-Acquired Pneumonia in Adults

Area of Science:

• Pulmonology
• Infectious Diseases
• Critical Care Medicine

Background:

• Community-acquired pneumonia (CAP) presents a wide clinical spectrum, from treatable outpatient cases with low mortality to emergency room presentations with over 40% mortality.
• Distinguishing pneumonia from acute bronchitis necessitates radiological evidence of infiltrate.

Purpose of the Study:

• To outline current guidelines and best practices for the diagnosis and management of community-acquired pneumonia.
• To emphasize risk stratification, appropriate antibiotic selection, and structured follow-up care.

Main Methods:

• A selective literature search of pertinent publications and current guidelines was conducted.
• The review focused on diagnostic criteria, risk prediction tools, and therapeutic strategies for CAP.

Main Results:

• Radiological infiltrate confirms pneumonia. Risk assessment should include CRB-65 criteria, comorbidities, and oxygenation.
• Mild pneumonia treatment involves amoxicillin (with clavulanic acid for comorbidities). Emergency room management focuses on organ dysfunction and sepsis, with IV beta-lactams and macrolides if needed.
• Treatment duration is 5-7 days. Monitoring cardiovascular complications is crucial. Structured follow-up includes managing comorbidities and preventive measures like vaccinations and smoking cessation.

Conclusions:

• Appropriate risk stratification and severity-adapted management are essential for CAP.
• Structured follow-up care and secondary prevention, particularly for patients with comorbidities, are critical for improving prognosis.